Literature DB >> 11453812

Detection of clinically amelanotic malignant melanoma and assessment of its margins by in vivo confocal scanning laser microscopy.

K J Busam1, K Hester, C Charles, D L Sachs, C R Antonescu, S Gonzalez, A C Halpern.   

Abstract

BACKGROUND: Near-infrared confocal scanning laser microscopy (CSLM) represents a novel imaging technique for in vivo microscopic analysis of skin lesions, including pigmented lesions.
OBJECTIVES: To investigate the feasibility of detecting a clinically amelanotic malignant cutaneous melanoma using CSLM and to explore the use of this technique for assessing its margins. PATIENTS AND METHODS: Two lesions from 2 patients were imaged and analyzed using CSLM. Sites suspected to represent melanoma or benign skin on CSLM were marked as such; then, biopsy specimens were obtained for diagnosis using conventional histological analysis. Both lesions were stained for melanin pigment and analyzed immunohistochemically for the expression of melanosomal markers. In 1 case, a biopsy specimen was also examined with electron microscopy.
RESULTS: The images obtained using CSLM allowed recognition of an abnormal intraepidermal melanocytic proliferation that was distinctly different from normal skin. Comparison of the sites examined using CSLM and subsequently using conventional histological methods revealed that CSLM correctly identified intraepidermal melanoma and benign skin. Fontana-Masson stains and immunohistochemical and ultrastructural studies showed that clinically amelanotic melanoma cells contained melanosomes and rare melanin granules.
CONCLUSIONS: We demonstrated, for the first time, the detection of clinically amelanotic melanoma using CSLM. This technique may aid in the early detection of clinically barely visible or nonpigmented melanomas and may facilitate preoperative noninvasive assessment of their margins.

Entities:  

Mesh:

Year:  2001        PMID: 11453812

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  16 in total

1.  Automated detection of malignant features in confocal microscopy on superficial spreading melanoma versus nevi.

Authors:  Dan Gareau; Ricky Hennessy; Eric Wan; Giovanni Pellacani; Steven L Jacques
Journal:  J Biomed Opt       Date:  2010 Nov-Dec       Impact factor: 3.170

2.  Detection and diagnosis of oral neoplasia with an optical coherence microscope.

Authors:  A L Clark; A Gillenwater; R Alizadeh-Naderi; A K El-Naggar; R Richards-Kortum
Journal:  J Biomed Opt       Date:  2004 Nov-Dec       Impact factor: 3.170

3.  Impact of in vivo reflectance confocal microscopy on the number needed to treat melanoma in doubtful lesions.

Authors:  I Alarcon; C Carrera; J Palou; L Alos; J Malvehy; S Puig
Journal:  Br J Dermatol       Date:  2014-04       Impact factor: 9.302

Review 4.  New diagnostic aids for melanoma.

Authors:  Laura Korb Ferris; Ryan J Harris
Journal:  Dermatol Clin       Date:  2012-07       Impact factor: 3.478

5.  In vitro and in vivo evaluation of melanin-binding decapeptide 4B4 radiolabeled with 177Lu, 166Ho, and 153Sm radiolanthanides for the purpose of targeted radionuclide therapy of melanoma.

Authors:  Beau Ballard; Zewei Jiang; Clifford E Soll; Ekaterina Revskaya; Cathy S Cutler; Ekaterina Dadachova; Lynn C Francesconi
Journal:  Cancer Biother Radiopharm       Date:  2011-10-04       Impact factor: 3.099

Review 6.  Reflectance confocal microscopy of skin in vivo: From bench to bedside.

Authors:  Milind Rajadhyaksha; Ashfaq Marghoob; Anthony Rossi; Allan C Halpern; Kishwer S Nehal
Journal:  Lasers Surg Med       Date:  2016-10-27       Impact factor: 4.025

7.  Confocal microscopy of skin cancers: translational advances toward clinical utility.

Authors:  Milind Rajadhyaksha
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2009

Review 8.  Current and emerging technologies in melanoma diagnosis: the state of the art.

Authors:  Estee L Psaty; Allan C Halpern
Journal:  Clin Dermatol       Date:  2009 Jan-Feb       Impact factor: 3.541

9.  Emerging technologies for the detection of melanoma: achieving better outcomes.

Authors:  Cila Herman
Journal:  Clin Cosmet Investig Dermatol       Date:  2012-11-12

10.  Safety and efficacy of 188-rhenium-labeled antibody to melanin in patients with metastatic melanoma.

Authors:  M Klein; M Lotem; T Peretz; S T Zwas; S Mizrachi; Y Liberman; R Chisin; J Schachter; I G Ron; G Iosilevsky; J A Kennedy; E Revskaya; A W de Kater; E Banaga; V Klutzaritz; N Friedmann; E Galun; G L Denardo; S J Denardo; A Casadevall; E Dadachova; G B Thornton
Journal:  J Skin Cancer       Date:  2013-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.